PYC Therapeutics (ASX:PYC) Short Ratio


ASX:PYC PYC Therapeutics Ltd ASX:PYC
36 GF Score
Price A$1.56
! 2 Warning Signs
View Full Analysis

What is PYC Therapeutics Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ASX:PYC
36GF Score
PYC Therapeutics Ltd ASX:PYC
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PYC Therapeutics Business Description

Other Exchanges PYCXF:USA
Address 6 Verdun Street, Harry Perkins Institute of Medical Research, Nedlands, Perth, WA, AUS, 6009
PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company's drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.
36GF Score

Get the complete analysis for ASX:PYC

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.56
Price